Table 1.
Treatment | SGOT (IU/dL) |
SGPT (IU/dL) |
SALP (IU/dL) |
Bilirubin (mg/dL) |
ALT (IU/dL) |
AST (IU/dL) |
ALP (IU/dL) |
Creatinine (mg/dL) |
---|---|---|---|---|---|---|---|---|
Control (vehicle only) |
40.11 ± 9.21 | 36.56 ± 8.30 | 86.41 ± 6.33 | 0.86 ± 2.11 | 43.54 ± 8.16 | 92.15 ± 7.00 | 274.16 ± 6.16 | 0.93 ± 5.16 |
LTLD1 | 40.00 ± 8.01 | 32.98 ± 6.80 | 84.21 ± 2.64 | 0.86 ± 2.96 | 42.76 ± 7.36 | 90.61 ± 6.01 | 284.16 ± 7.11 | 0.90 ± 2.74 |
LTLD2 | 42.18 ± 4.39 | 35.41 ± 7.21 | 82.25 ± 8.86 | 0.90 ± 1.46 | 40.24 ± 6.00 | 90.87 ± 4.11 | 261.32 ± 7.21 | 0.91 ± 2.90 |
The data are reported as the mean ± SEM (n = 10).